A spray containing extracts of oat plantlets and Uncaria tomentosa relieves pain associated with chronic inflammatory skin diseases and dermatological procedures
Background Inflammation from skin conditions such as psoriasis, eczema‐like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post‐acts) can result in intense itching and cutaneous pain. Dermo‐cosmetics containing plant extracts have been shown to reduce or allevia...
Saved in:
Published in | Journal of the European Academy of Dermatology and Venereology Vol. 34; no. S2; pp. 3 - 11 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.06.2020
|
Subjects | |
Online Access | Get full text |
ISSN | 0926-9959 1468-3083 1468-3083 |
DOI | 10.1111/jdv.16428 |
Cover
Abstract | Background
Inflammation from skin conditions such as psoriasis, eczema‐like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post‐acts) can result in intense itching and cutaneous pain. Dermo‐cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms.
Objectives
Assessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures.
Methods
Data from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment‐emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre‐ and postapplication.
Results
A total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies.
Conclusions
The dermo‐cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases. |
---|---|
AbstractList | Background
Inflammation from skin conditions such as psoriasis, eczema‐like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post‐acts) can result in intense itching and cutaneous pain. Dermo‐cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms.
Objectives
Assessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures.
Methods
Data from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment‐emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre‐ and postapplication.
Results
A total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies.
Conclusions
The dermo‐cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases. Inflammation from skin conditions such as psoriasis, eczema-like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post-acts) can result in intense itching and cutaneous pain. Dermo-cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms. Assessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures. Data from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment-emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre- and postapplication. A total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies. The dermo-cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases. Inflammation from skin conditions such as psoriasis, eczema-like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post-acts) can result in intense itching and cutaneous pain. Dermo-cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms.BACKGROUNDInflammation from skin conditions such as psoriasis, eczema-like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post-acts) can result in intense itching and cutaneous pain. Dermo-cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms.Assessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures.OBJECTIVESAssessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures.Data from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment-emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre- and postapplication.METHODSData from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment-emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre- and postapplication.A total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies.RESULTSA total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies.The dermo-cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases.CONCLUSIONSThe dermo-cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases. |
Author | Saint Aroman, M. Reich, A. Guillot, P. Carballido, F. Lopez Estebaranz, J.L. Bahadoran, P. |
Author_xml | – sequence: 1 givenname: A. orcidid: 0000-0002-5573-1754 surname: Reich fullname: Reich, A. organization: University of Rzeszow – sequence: 2 givenname: J.L. surname: Lopez Estebaranz fullname: Lopez Estebaranz, J.L. organization: University Hospital Fundacion Alcorcon – sequence: 3 givenname: P. surname: Bahadoran fullname: Bahadoran, P. organization: Hôpital de l’Archet – sequence: 4 givenname: P. surname: Guillot fullname: Guillot, P. organization: Wallerstein Medical Center – sequence: 5 givenname: F. surname: Carballido fullname: Carballido, F. organization: Pierre Fabre Dermo‐Cosmétique – sequence: 6 givenname: M. orcidid: 0000-0001-6124-5122 surname: Saint Aroman fullname: Saint Aroman, M. email: marketa.saint.aroman@pierre-fabre.com organization: Pierre Fabre Dermo‐Cosmétique |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32476176$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1O3TAQha2KqlxoF32BysuyCNhO4jhLRP-F1A2wjeZOJmDq2KntC9zH6ZvW9NIuKrX2YqTxN2d0fA7Yng-eGHstxbEs5-R2vDuWulHmGVvJRpuqFqbeYyvRK131fdvvs4OUboUQUrbmBduvVdNp2ekV-3HK0xJhyzH4DNZbf83pIUfAnHiYeIDMFwc-OyoN8CO_9AjRAs9hJp9DAh7JWbqjxJciwCGlgBYyjfze5huONzF4i9z6ycE8Qw5xy9O3Qo42ESTayY4UH99cuLYIji8xII2bSOklez6BS_TqqR6yyw_vL84-VedfP34-Oz2vsNbCVKoFUhqLLYmqFGhBqV6A7rpGN2ujFE2oWql7s1aAAsF0zTgZhVNLY4P1IXu70y2rv28o5WG2CckV8xQ2aVCNMG3dl1vQN0_oZj3TOCzRzhC3w-9vLcDRDsAYUoo0_UGkGB4jG0pkw6_ICnvyF4s2Q7YljwjW_W_i3jra_lt6-PLuajfxE7k8q6w |
CitedBy_id | crossref_primary_10_1111_jdv_18740 crossref_primary_10_3390_molecules26185564 crossref_primary_10_56083_RCV3N11_143 crossref_primary_10_1111_jdv_17876 |
Cites_doi | 10.1055/s-0030-1250649 10.1016/j.pbb.2005.04.004 10.1201/b16573-10 10.1155/2019/3706315 10.1002/ejp.768 10.2147/CCID.S177614 10.1111/jdv.14891 10.1007/s00424-013-1284-2 10.1186/s40535-014-0003-1 10.1016/j.anai.2017.09.076 10.1248/bpb.28.601 10.1016/j.jid.2019.03.715 10.1111/ajd.12715 10.3390/antiox6010012 10.1016/j.sder.2010.03.001 10.2340/00015555-1965 10.1111/jdv.14410 10.1007/s13555-019-0280-7 10.3390/biomedicines6010012 10.1111/jdv.14846 10.1007/s40271-019-00373-y 10.1111/jdv.14077 10.1016/S0140-6736(15)00149-X 10.1007/s00018-015-1904-4 10.1159/000446009 10.1007/PL00000268 |
ContentType | Journal Article |
Copyright | 2020 European Academy of Dermatology and Venereology 2020 European Academy of Dermatology and Venereology. |
Copyright_xml | – notice: 2020 European Academy of Dermatology and Venereology – notice: 2020 European Academy of Dermatology and Venereology. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/jdv.16428 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-3083 |
EndPage | 11 |
ExternalDocumentID | 32476176 10_1111_jdv_16428 JDV16428 |
Genre | article Journal Article |
GroupedDBID | --- --K .3N .GA .Y3 05W 0R~ 10A 1B1 1OB 1OC 1~5 29L 31~ 33P 36B 3SF 4.4 4G. 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AAHQN AAIPD AALRI AAMNL AANHP AANLZ AAONW AAQFI AAQXK AASGY AAXRX AAXUO AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABQWH ABWVN ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADZMN AE3 AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFTJW AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CO8 COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD ESX EX3 F00 F01 F04 F5P FDB FEDTE FGOYB FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 NF~ NQ- O66 O9- OIG OVD OZT P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K R2- RIG RIWAO RJQFR ROL RPZ RX1 SAMSI SEW SUPJJ TEORI UB1 UHS W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX ACVFH ADCNI AEUPX AEYWJ AFPUW AGHNM AGQPQ AGYGG AIGII CITATION CGR CUY CVF ECM EIF NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
ID | FETCH-LOGICAL-c3608-25ae26c7611c2c76a5a2290a677464b822efc251698b2ac0ca874df82cf5ed4c3 |
IEDL.DBID | DR2 |
ISSN | 0926-9959 1468-3083 |
IngestDate | Fri Jul 11 07:17:45 EDT 2025 Thu Apr 03 07:04:43 EDT 2025 Tue Jul 01 04:12:08 EDT 2025 Thu Apr 24 22:52:25 EDT 2025 Wed Jan 22 16:35:24 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | S2 |
Language | English |
License | 2020 European Academy of Dermatology and Venereology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3608-25ae26c7611c2c76a5a2290a677464b822efc251698b2ac0ca874df82cf5ed4c3 |
Notes | AR has been a consultant or speaker for AbbVie, Bioderma, Celgene, Chema Elektromet, Eli Lilly, Galderma, Janssen, Leo Pharma, Medac, Menlo Therapeutics, Novartis, Pierre‐Fabre, Sandoz and Trevi; and a principal Investigator or sub‐investigator in clinical trials sponsored by AbbVie, Drug Delivery Solutions Ltd, Galderma, Genentech, Janssen, Kymab Limited, Leo Pharma, Menlo Therapeutics, MetrioPharm, MSD, Novartis, Pfizer and Trev. JLE has been a consultant or speaker for Abbvie, Novartis, Leo, Galderma, Lilly, Janssen and Almirall. PB has received honoraria as a speaker from Pierre Fabre Dermo‐Cosmétique and has been reimbursed by Pierre Fabre Dermo‐Cosmétique for international conference attendance. FC and MSA work within the Pierre Fabre Dermo‐Cosmétique company, in the A‐DERMA brand. PG declares no COIs. Conflicts of interest Funding sources This study was funded by Pierre Fabre Dermo‐Cosmétique. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-5573-1754 0000-0001-6124-5122 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.16428 |
PMID | 32476176 |
PQID | 2408539393 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2408539393 pubmed_primary_32476176 crossref_primary_10_1111_jdv_16428 crossref_citationtrail_10_1111_jdv_16428 wiley_primary_10_1111_jdv_16428_JDV16428 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | June 2020 2020-06-00 2020-Jun 20200601 |
PublicationDateYYYYMMDD | 2020-06-01 |
PublicationDate_xml | – month: 06 year: 2020 text: June 2020 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of the European Academy of Dermatology and Venereology |
PublicationTitleAlternate | J Eur Acad Dermatol Venereol |
PublicationYear | 2020 |
References | 2017; 119 2017; 6 2019; 2019 2019; 9 2001; 50 2013; 87 2015; 95 2015; 72 2019; 12 2016; 387 2011; 77 2013; 465 2016; 50 2005; 81 2005; 28 2014; 1 2018; 6 2017; 31 2010; 29 2019 2016; 20 2014 2018; 11 2018; 32 2018; 59 Saint Aroman M (e_1_2_6_16_1) 2018; 11 e_1_2_6_10_1 e_1_2_6_19_1 e_1_2_6_14_1 Weigle N (e_1_2_6_11_1) 2013; 87 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_21_1 e_1_2_6_20_1 Borgia F (e_1_2_6_13_1) 2018; 6 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – volume: 95 start-page: 432 year: 2015 end-page: 438 article-title: Psoriasis and skin pain: instrumental and biological evaluations publication-title: Acta Derm Venereol – volume: 9 start-page: 71 year: 2019 end-page: 102 article-title: Tolerability of topical treatments for atopic dermatitis publication-title: Dermatol Ther (Heidelb) – volume: 119 start-page: 548 year: 2017 end-page: 552 article-title: Burden of skin pain in atopic dermatitis publication-title: Ann Allergy Asthma Immunol – volume: 81 start-page: 466 year: 2005 end-page: 477 article-title: Involvement of 5‐HT2 receptors in the antinociceptive effect of publication-title: Pharmacol Biochem Behav – volume: 2019 start-page: 15 year: 2019 article-title: Skin acute wound healing: a comprehensive review publication-title: Int J Inflamm – volume: 1 start-page: 3 year: 2014 article-title: The immunological and genetic aspects in psoriasis publication-title: Appl Inform – volume: 6 year: 2018 article-title: Early and late onset side effects of photodynamic therapy publication-title: Biomedicines – volume: 11 start-page: 579 year: 2018 end-page: 589 article-title: Efficacy of a repair cream containing Rhealba oat plantlets extract l‐ALA‐l‐GLU dipeptide, and hyaluronic acid in wound healing following dermatological acts: a meta‐analysis of >2,000 patients in eight countries corroborated by a dermatopediatric clinical case publication-title: Clin Cosmet Investig Dermatol – volume: 465 start-page: 1671 year: 2013 end-page: 1685 article-title: New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms? publication-title: Pflugers Arch – volume: 32 start-page: 1 issue: Suppl 1 year: 2018 end-page: 15 article-title: Effects of a protein‐free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients publication-title: J Eur Acad Dermatol Venereol – volume: 50 start-page: 442 year: 2001 end-page: 448 article-title: Efficacy and safety of freeze‐dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species publication-title: Inflamm Res – year: 2014 – volume: 6 start-page: 12 year: 2017 article-title: Proanthocyanidin characterization and bioactivity of extracts from different parts of L. (Cat’s Claw) publication-title: Antioxidants (Basel) – volume: 31 start-page: 3 issue: Suppl 6 year: 2017 end-page: 18 article-title: Fragility of epidermis: acne and post‐procedure lesional skin publication-title: J Eur Acad Dermatol Venereol – volume: 32 start-page: 657 year: 2018 end-page: 682 article-title: Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I publication-title: J Eur Acad Dermatol Venereol – volume: 29 start-page: 3 year: 2010 end-page: 9 article-title: New insights in the immunologic basis of psoriasis publication-title: Semin Cutan Med Surg – volume: 20 start-page: 41 year: 2016 end-page: 46 article-title: Pruritus in psoriasis: An update publication-title: Eur J Pain – volume: 28 start-page: 601 year: 2005 end-page: 606 article-title: Avena Rhealba inhibits A23187‐stimulated arachidonic acid mobilization, eicosanoid release, and cPLA2 expression in human keratinocytes: potential in cutaneous inflammatory disorders publication-title: Biol Pharm Bull – volume: 72 start-page: 3201 year: 2015 end-page: 3223 article-title: Molecular and cellular mechanisms that initiate pain and itch publication-title: Cell Mol Life Sci – volume: 50 start-page: 1 year: 2016 end-page: 4 article-title: Classification of Itch publication-title: Curr Probl Dermatol – volume: 77 start-page: 900 year: 2011 end-page: 906 article-title: Rhealba\xAE oat plantlet extract: evidence of protein‐free content and assessment of regulatory activity on immune inflammatory mediators publication-title: Planta Med – volume: 87 start-page: 626 year: 2013 end-page: 633 article-title: Psoriasis publication-title: Am Fam Physician. – volume: 31 start-page: 1 issue: Suppl 1 year: 2017 end-page: 7 article-title: Efficacy of a Rhealba Oat Extract-based emollient on chronic pruritus in elderly French outpatients. Oat Extract‐based emollient on chronic pruritus in elderly French outpatients publication-title: J Eur Acad Dermatol Venereol – year: 2019 – volume: 12 start-page: 445 year: 2019 end-page: 459 article-title: Patient‐reported outcome measures in atopic dermatitis and chronic hand eczema in adults publication-title: Patient – volume: 387 start-page: 1109 year: 2016 end-page: 1122 article-title: Atopic dermatitis publication-title: Lancet – volume: 59 start-page: 171 year: 2018 end-page: 181 article-title: Chemical peels: A review of current practice publication-title: Australas J Dermatol – ident: e_1_2_6_17_1 doi: 10.1055/s-0030-1250649 – ident: e_1_2_6_20_1 doi: 10.1016/j.pbb.2005.04.004 – ident: e_1_2_6_4_1 doi: 10.1201/b16573-10 – ident: e_1_2_6_5_1 doi: 10.1155/2019/3706315 – ident: e_1_2_6_26_1 doi: 10.1002/ejp.768 – volume: 11 start-page: 579 year: 2018 ident: e_1_2_6_16_1 article-title: Efficacy of a repair cream containing Rhealba oat plantlets extract l‐ALA‐l‐GLU dipeptide, and hyaluronic acid in wound healing following dermatological acts: a meta‐analysis of >2,000 patients in eight countries corroborated by a dermatopediatric clinical case publication-title: Clin Cosmet Investig Dermatol doi: 10.2147/CCID.S177614 – ident: e_1_2_6_22_1 doi: 10.1111/jdv.14891 – ident: e_1_2_6_3_1 doi: 10.1007/s00424-013-1284-2 – ident: e_1_2_6_9_1 doi: 10.1186/s40535-014-0003-1 – volume: 87 start-page: 626 year: 2013 ident: e_1_2_6_11_1 article-title: Psoriasis publication-title: Am Fam Physician. – ident: e_1_2_6_7_1 doi: 10.1016/j.anai.2017.09.076 – ident: e_1_2_6_23_1 doi: 10.1248/bpb.28.601 – ident: e_1_2_6_21_1 doi: 10.1016/j.jid.2019.03.715 – ident: e_1_2_6_14_1 doi: 10.1111/ajd.12715 – ident: e_1_2_6_24_1 doi: 10.3390/antiox6010012 – ident: e_1_2_6_8_1 doi: 10.1016/j.sder.2010.03.001 – ident: e_1_2_6_27_1 doi: 10.2340/00015555-1965 – ident: e_1_2_6_15_1 doi: 10.1111/jdv.14410 – ident: e_1_2_6_6_1 doi: 10.1007/s13555-019-0280-7 – volume: 6 year: 2018 ident: e_1_2_6_13_1 article-title: Early and late onset side effects of photodynamic therapy publication-title: Biomedicines doi: 10.3390/biomedicines6010012 – ident: e_1_2_6_19_1 doi: 10.1111/jdv.14846 – ident: e_1_2_6_28_1 doi: 10.1007/s40271-019-00373-y – ident: e_1_2_6_18_1 doi: 10.1111/jdv.14077 – ident: e_1_2_6_10_1 doi: 10.1016/S0140-6736(15)00149-X – ident: e_1_2_6_2_1 doi: 10.1007/s00018-015-1904-4 – ident: e_1_2_6_12_1 doi: 10.1159/000446009 – ident: e_1_2_6_25_1 doi: 10.1007/PL00000268 |
SSID | ssj0001158 |
Score | 2.298159 |
Snippet | Background
Inflammation from skin conditions such as psoriasis, eczema‐like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures... Inflammation from skin conditions such as psoriasis, eczema-like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3 |
SubjectTerms | Avena - chemistry Cat's Claw - chemistry Chronic Disease Dermatitis - complications Dermatitis - drug therapy Humans Pain - drug therapy Pain - etiology Plant Extracts - pharmacology Plant Extracts - therapeutic use |
Title | A spray containing extracts of oat plantlets and Uncaria tomentosa relieves pain associated with chronic inflammatory skin diseases and dermatological procedures |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjdv.16428 https://www.ncbi.nlm.nih.gov/pubmed/32476176 https://www.proquest.com/docview/2408539393 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b9swECYMD0GXNo8-3DTBpejQRYYlUZSMTkHcwDDgDEFdeCggnEhqsSsJpmwg_Tf9pzlSktv0AQSBBmk4HUjxHh951EfGPvAEhYxz7nGV0AQlktIbZxn3JA9j5Ys80W7BbX4jpgs-W0bLHvvU_QvT8EPsF9ysZ7h4bR0cM_O7k6vd0LfomeKvHwrLmz-5_UUdRUjHReFxIDzLqdWyCrldPN2bD3PRXwDzIV51Cef6BfvWNbXZZ7IabutsKH_8weL4xL4csuctEIXLxnKOWE8Xx-xg3pbaT9jPSzDVBu_AbmZvjpEACuT2pyoDZQ4l1lCtaVxo4A1goWBRSJp4I9SW1KEuDcKGmqV32kBFCgBbS9AK7OovyIaXF8jGySy_u3I_mBVJtlWjRq2yuaPuYjS4jKu2G21essX15y9XU689z8GToRiRQ0aoA7IM4fsyoBtGaNnmURAEFTwjqKJzGdjCXZIFKEcSk5irPAlkHmnFZfiK9Yuy0G8Y5GOFOsJYkxJOIRKzPIm1DoXlswvjaMA-diObypbs3J65sU73kx61S90nH7D3e9GqYfj4l9BFZx4p-Z8tqmChy61JHUVcOKZrwF43drNXQ2CVOhsLao0b_f_rT2eTr-7h7eNFT9mzwE7-3ZLQO9avN1t9Rgipzs6dK9wDRAAQNw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgGX8mrp8hwQBy5ZdRPHyUpcKkq1lG4PqIt6QdHEdi5tk9UmuxL8G_4pM06yUB5ShXJIDs7IjmfG38w4nwFeq5S0SQoVKJtygBIbE4zzXAVGRYkd6SJ1PuE2PdGTmTo6i8824G3_L0zLD7FOuIlleH8tBi4J6V-t3K6GI4HPN-CmYqAhodfBp5_kUYx1vB8ehzoQVq2OV8jv4-lfvboa_QExryJWv-Qc3oUvfWfbnSbnw2WTD82333gc_3c092Crw6K43yrPfdhw5QO4Ne2q7Q_h-z7W8wV9RdnP3p4kgezL5b-qGqsCK2pwfsFTw3NfI5UWZ6Xh2JuwEV6HpqoJF9wvt3I1zlkAUqcMzqIkgNG01LzIas6aeekr_lifc8uucNSKtbJ8NL2bRr_o2uXC1dswO3x_-m4SdEc6BCbSe2yTMbmQlUOPRibkG8UkhPOkGYVqlTNacYUJpXaX5iGZPUNpomyRhqaInVUm2oHNsirdLmAxtuRiShwLUewlKS_SxLlIC6VdlMQDeNNPbWY6vnM5duMiW8c9dpX5Tz6AV-um85bk42-NXvb6kbEJSl2FSlct68yzxEVjvgbwqFWctRjGqzzYRHNv_PT_W352dPDZPzy-ftMXcHtyOj3Ojj-cfHwCd0LJBfgM0VPYbBZL94wBU5M_93bxAzPGFFY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVqq4lJZXt7QwIA5csmITx8mqp6pl1RZaIcSiHpCiiR-Xtkm0ya4E_4Z_ythJthSohFAOycEZ2ZmHP884nwFei5SkSqwIhE55gRIrFYzzXARKRIkeSZsan3A7O5fHU3F6EV-swH7_L0zLD7FMuDnP8PHaOXil7a9OrhfDkUPP92BNSEYSDhF9uuGOYqjjw_A4lIEj1epohfw2nv7V25PRHwjzNmD1M87kAXzt-9puNLkczpt8qL7_RuP4n4PZhI0OieJBazpbsGKKh7B-1tXaH8GPA6yrGX1Dt5u9PUcCOZK7v6pqLC2W1GB1xYphzddIhcZpoXjlTdg4VoemrAln3C2zMDVWLACpMwWj0aV_UbXEvMhGznZ57ev9WF9yy65s1IrVbvJo-iCNfsrV85mpH8N08u7z4XHQHegQqIg1FIQxmZBNQ45GKuQbxeTo5kkyBpUiZ6xirApd5S7NQ1JvFaWJ0DYNlY2NFip6AqtFWZhtQDvWZGJKDAsRHCMpt2liTCQdoV2UxAN402s2Ux3buTt04ypbrnr0IvOffACvlk2rluLjb41e9uaRsQO6qgoVppzXmeeIi8Z8DeBpazdLMYxWebCJ5N547d8tPzs9-uIfdv696QtY_3g0yT6cnL9_BvdDlwjw6aFdWG1mc7PHaKnJn3uv-An2NBMF |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+spray+containing+extracts+of+oat+plantlets+and+Uncaria+tomentosa+relieves+pain+associated+with+chronic+inflammatory+skin+diseases+and+dermatological+procedures&rft.jtitle=Journal+of+the+European+Academy+of+Dermatology+and+Venereology&rft.au=Reich%2C+A.&rft.au=Lopez+Estebaranz%2C+J.L.&rft.au=Bahadoran%2C+P.&rft.au=Guillot%2C+P.&rft.date=2020-06-01&rft.issn=0926-9959&rft.eissn=1468-3083&rft.volume=34&rft.spage=3&rft.epage=11&rft_id=info:doi/10.1111%2Fjdv.16428&rft.externalDBID=10.1111%252Fjdv.16428&rft.externalDocID=JDV16428 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0926-9959&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0926-9959&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0926-9959&client=summon |